` PRFX (PainReform Ltd) vs S&P 500 Comparison - Alpha Spread

PRFX
vs
S&P 500

Over the past 12 months, PRFX has underperformed S&P 500, delivering a return of -80% compared to the S&P 500's +14% growth.

Stocks Performance
PRFX vs S&P 500

Loading
PRFX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PRFX vs S&P 500

Performance Gap Between PRFX and GSPC
HIDDEN
Show

Performance By Year
PRFX vs S&P 500

Loading
PRFX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PainReform Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PainReform Ltd
Glance View

Market Cap
3.5m USD
Industry
Pharmaceuticals

PainReform Ltd. operates as a pharmaceutical company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

PRFX Intrinsic Value
HIDDEN
Show
Back to Top